Cargando…
CD8(+) T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination
Almost three years into the SARS-CoV-2 pandemic, hybrid immunity is highly prevalent worldwide and more protective than vaccination or prior infection alone. Given emerging resistance of variant strains to neutralizing antibodies (nAb), it is likely that T cells contribute to this protection. To und...
Autores principales: | Ford, Emily S., Mayer-Blackwell, Koshlan, Jing, Lichen, Sholukh, Anton M., St. Germain, Russell, Bossard, Emily L., Xie, Hong, Pulliam, Thomas H., Jani, Saumya, Selke, Stacy, Burrow, Carlissa J., McClurkan, Christopher L., Wald, Anna, Holbrook, Michael R., Eaton, Brett, Eudy, Elizabeth, Murphy, Michael, Postnikova, Elena, Robins, Harlan S., Elyanow, Rebecca, Gittelman, Rachel M., Ecsedi, Matyas, Wilcox, Elise, Chapuis, Aude G., Fiore-Gartland, Andrew, Koelle, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580387/ https://www.ncbi.nlm.nih.gov/pubmed/36263073 http://dx.doi.org/10.21203/rs.3.rs-2146712/v1 |
Ejemplares similares
-
Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in Humans
por: James, Charlotte A., et al.
Publicado: (2022) -
TCR meta-clonotypes for biomarker discovery with tcrdist3: identification of public, HLA-restricted SARS-CoV-2 associated TCR features
por: Mayer-Blackwell, Koshlan, et al.
Publicado: (2021) -
TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs
por: Mayer-Blackwell, Koshlan, et al.
Publicado: (2021) -
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
por: Elyanow, Rebecca, et al.
Publicado: (2021) -
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
por: Elyanow, Rebecca, et al.
Publicado: (2022)